The campaign targets 63 endemic districts across Bihar, Jharkhand, Karnataka, Odisha, Telangana, and Uttar Pradesh
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
These abstracts report on the company's three lead drug candidates, including olverembatinib
Updated results from the four studies will be presented in Oral Reports or Posters at the ASCO Annual Meeting
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Subscribe To Our Newsletter & Stay Updated
